484 related articles for article (PubMed ID: 15596830)
41. Double strand interaction is the predominant pathway for intermolecular recombination of adeno-associated viral genomes.
Yue Y; Duan D
Virology; 2003 Aug; 313(1):1-7. PubMed ID: 12951015
[TBL] [Abstract][Full Text] [Related]
42. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography.
Tamayose K; Hirai Y; Shimada T
Hum Gene Ther; 1996 Mar; 7(4):507-13. PubMed ID: 8800745
[TBL] [Abstract][Full Text] [Related]
43. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
44. Adeno-associated virus (AAV) site-specific recombination does not require a Rep-dependent origin of replication within the AAV terminal repeat.
Young SM; Samulski RJ
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13525-30. PubMed ID: 11707592
[TBL] [Abstract][Full Text] [Related]
45. Gene expression from adeno-associated virus vectors in airway epithelial cells.
Flotte TR; Solow R; Owens RA; Afione S; Zeitlin PL; Carter BJ
Am J Respir Cell Mol Biol; 1992 Sep; 7(3):349-56. PubMed ID: 1325813
[TBL] [Abstract][Full Text] [Related]
46. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
[TBL] [Abstract][Full Text] [Related]
47. Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting.
Carvalho LS; Turunen HT; Wassmer SJ; Luna-Velez MV; Xiao R; Bennett J; Vandenberghe LH
Front Neurosci; 2017; 11():503. PubMed ID: 28943836
[TBL] [Abstract][Full Text] [Related]
48. Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes.
Chiorini JA; Afione S; Kotin RM
J Virol; 1999 May; 73(5):4293-8. PubMed ID: 10196327
[TBL] [Abstract][Full Text] [Related]
49. Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice.
Koo T; Popplewell L; Athanasopoulos T; Dickson G
Hum Gene Ther; 2014 Feb; 25(2):98-108. PubMed ID: 24191945
[TBL] [Abstract][Full Text] [Related]
50. Adeno-associated virus general transduction vectors: analysis of proviral structures.
McLaughlin SK; Collis P; Hermonat PL; Muzyczka N
J Virol; 1988 Jun; 62(6):1963-73. PubMed ID: 2835501
[TBL] [Abstract][Full Text] [Related]
51. Direct ITR-to-ITR Nanopore Sequencing of AAV Vector Genomes.
Namkung S; Tran NT; Manokaran S; He R; Su Q; Xie J; Gao G; Tai PWL
Hum Gene Ther; 2022 Nov; 33(21-22):1187-1196. PubMed ID: 36178359
[TBL] [Abstract][Full Text] [Related]
52. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity.
Wu J; Zhao W; Zhong L; Han Z; Li B; Ma W; Weigel-Kelley KA; Warrington KH; Srivastava A
Hum Gene Ther; 2007 Feb; 18(2):171-82. PubMed ID: 17328683
[TBL] [Abstract][Full Text] [Related]
53. Effect of genome size on AAV vector packaging.
Wu Z; Yang H; Colosi P
Mol Ther; 2010 Jan; 18(1):80-6. PubMed ID: 19904234
[TBL] [Abstract][Full Text] [Related]
54. Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction.
Hauck B; Zhao W; High K; Xiao W
J Virol; 2004 Dec; 78(24):13678-86. PubMed ID: 15564477
[TBL] [Abstract][Full Text] [Related]
55. Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation.
Wang Y; Ling C; Song L; Wang L; Aslanidi GV; Tan M; Ling C; Srivastava A
Hum Gene Ther Methods; 2012 Aug; 23(4):225-33. PubMed ID: 22966785
[TBL] [Abstract][Full Text] [Related]
56. Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.
Srivastava CH; Samulski RJ; Lu L; Larsen SH; Srivastava A
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8078-82. PubMed ID: 2554300
[TBL] [Abstract][Full Text] [Related]
57. Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy.
Reich SJ; Auricchio A; Hildinger M; Glover E; Maguire AM; Wilson JM; Bennett J
Hum Gene Ther; 2003 Jan; 14(1):37-44. PubMed ID: 12573057
[TBL] [Abstract][Full Text] [Related]
58. Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A.
Dyka FM; Boye SL; Chiodo VA; Hauswirth WW; Boye SE
Hum Gene Ther Methods; 2014 Apr; 25(2):166-77. PubMed ID: 24568220
[TBL] [Abstract][Full Text] [Related]
59. Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector.
Palombo F; Monciotti A; Recchia A; Cortese R; Ciliberto G; La Monica N
J Virol; 1998 Jun; 72(6):5025-34. PubMed ID: 9573272
[TBL] [Abstract][Full Text] [Related]
60. AAV as a viral vector for human gene therapy. Generation of recombinant virus.
Rolling F; Samulski RJ
Mol Biotechnol; 1995 Feb; 3(1):9-15. PubMed ID: 7606507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
